Drug profile · INN
tenofovir disoproxil + emtricitabine + efavirenz
TENOFOVIR DISOPROXIL EMTRICITABINE EFAVIRENZ VIATRIS 300/200/600
tenofovir disoproxil + emtricitabine + efavirenz (TENOFOVIR DISOPROXIL EMTRICITABINE EFAVIRENZ VIATRIS 300/200/600) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
Drug details — tenofovir disoproxil + emtricitabine + efavirenz
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.81
Quick answer
tenofovir disoproxil + emtricitabine + efavirenz (TENOFOVIR DISOPROXIL EMTRICITABINE EFAVIRENZ VIATRIS 300/200/600) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is tenofovir disoproxil + emtricitabine + efavirenz?
tenofovir disoproxil + emtricitabine + efavirenz (TENOFOVIR DISOPROXIL EMTRICITABINE EFAVIRENZ VIATRIS 300/200/600) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
What is the brand name for tenofovir disoproxil + emtricitabine + efavirenz?
TENOFOVIR DISOPROXIL EMTRICITABINE EFAVIRENZ VIATRIS 300/200/600 is a marketed brand name for tenofovir disoproxil + emtricitabine + efavirenz. Check FDA Drugs@FDA for the current US label holder and prescribing information.